These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 2311984)

  • 21. Analysis of response to ursodeoxycholic acid for gallstone dissolution.
    Bateson MC; Hill A; Bouchier IA
    Digestion; 1980; 20(5):358-64. PubMed ID: 7390061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of artificial depletion of the bile acid pool in man.
    Jazrawi RP; Bridges C; Joseph AE; Northfield TC
    Gut; 1986 Jul; 27(7):771-7. PubMed ID: 3732888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diurnal variation in cholesterol saturation of gall-bladder bile.
    Kupfer RM; Northfield TC
    Gut; 1983 Oct; 24(10):950-3. PubMed ID: 6684613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes of bile acid and lipid composition in blood and bile in the clinical course after the initiation of cheno- and ursodeoxycholic acid therapy in patients with cholesterol gallstones.
    Iwamura K
    Tokai J Exp Clin Med; 1982 Nov; 7(6):671-83. PubMed ID: 7184199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biliary lipids, bile acids, and gallbladder function in the human female: effects of contraceptive steroids.
    Kern F; Everson GT; DeMark B; McKinley C; Showalter R; Braverman DZ; Szczepanik-Van Leeuwen P; Klein PD
    J Lab Clin Med; 1982 Jun; 99(6):798-805. PubMed ID: 7077124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in biliary lipid and biliary bile acid composition in patients after administration of ursodeoxycholic acid.
    Makino I; Nakagawa S
    J Lipid Res; 1978 Aug; 19(6):723-8. PubMed ID: 690512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Influence of efferent biliary ducts on the composition of bile acids. Studies on subjects with cholesterol gall stones and a stone-free control group].
    Brühl W
    Z Gastroenterol; 1975 Dec; 13(8):690-4. PubMed ID: 1224757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Ursodeoxycholic acid in the treatment of gallbladder lithiasis].
    Mamianetti A; Labonia NA; Lafont D; Fiordalisi HH
    Acta Gastroenterol Latinoam; 1982; 12(1):33-8. PubMed ID: 7136453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biliary lipid output during three meals and an overnight fast. II. Effect of chenodeoxycholic acid treatment in gallstone subjects.
    Northfield TC; LaRusso NF; Hofmann AF; Thistle JL
    Gut; 1975 Jan; 16(1):12-7. PubMed ID: 1140620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ursodeoxycholic acid ingestion after ileal resection. Effect on biliary bile acid and lipid composition.
    LaRusso NF; Thistle JL
    Dig Dis Sci; 1981 Aug; 26(8):705-9. PubMed ID: 7261834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biliary lipid composition in cholesterol microlithiasis.
    Fracchia M; Pellegrino S; Secreto P; Gallo L; Masoero G; Pera A; Galatola G
    Gut; 2001 May; 48(5):702-6. PubMed ID: 11302972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intermittent secretion of abnormal bile in patients with cholesterol gall stones.
    Smallwood RA; Jablonski P; Watts JM
    Br Med J; 1972 Nov; 4(5835):263-6. PubMed ID: 5083887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative ultrastructural studies of gall bladder epithelium in gall stone free subjects and patients with gall stones.
    Sahlin S; Ahlberg J; Einarsson K; Henriksson R; Danielsson A
    Gut; 1990 Jan; 31(1):100-5. PubMed ID: 2318423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mucin in gall bladder bile of gall stone patients: influence of treatment with chenodeoxycholic acid and ursodeoxycholic acid.
    Sahlin S; Danielsson A; Angelin B; Reihnér E; Henriksson R; Einarsson K
    Gut; 1988 Nov; 29(11):1506-10. PubMed ID: 3209106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biliary lipid synthesis and secretion in gallstone patients before and during treatment with chenodeoxycholic acid.
    Key PH; Bonorris GG; Marks JW; Chung A; Schoenfield LJ
    J Lab Clin Med; 1980 Jun; 95(6):816-26. PubMed ID: 7381293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of biliary bile acid composition on biliary cholesterol saturation in gallstone patients treated with chenodeoxycholic acid and/or ursodeoxycholic acid.
    Stiehl A; Raedsch R; Czygan P; Götz R; Männer C; Walker S; Kommerell B
    Gastroenterology; 1980 Dec; 79(6):1192-8. PubMed ID: 7439628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of dietary sucrose on factors influencing cholesterol gall stone formation.
    Werner D; Emmett PM; Heaton KW
    Gut; 1984 Mar; 25(3):269-74. PubMed ID: 6698443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of chenodeoxycholic acid and ursodeoxycholic acid for lowering cholesterol saturation index of gallbladder in patients with a sphincterotomy.
    Meier PB; Ansel HJ; Shafer RB; Duane WC
    Gastroenterology; 1988 Dec; 95(6):1595-600. PubMed ID: 3181682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ursocholic acid: bile acid and bile lipid dose response and clinical studies in patients with gall stones.
    Howard PJ; Gleeson D; Murphy GM; Dowling RH
    Gut; 1989 Jan; 30(1):97-103. PubMed ID: 2920932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of primary bile acid ingestion on bile acid metabolism and biliary lipid secretion in gallstone patients.
    LaRusso NF; Hoffman NE; Hofmann AF; Northfield TC; Thistle JL
    Gastroenterology; 1975 Dec; 69(6):1301-14. PubMed ID: 1193329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.